Literature DB >> 19582475

Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells.

Hongyan Gu1, Shuyun Rao, Jie Zhao, Jia Wang, Rong Mu, Jingjing Rong, Lei Tao, Qi Qi, Qidong You, Qinglong Guo.   

Abstract

PURPOSE: In this study, we investigated the correlation between p53 and bcl-2 in gambogic acid (GA)-induced apoptosis.
METHOD: MTT assay was employed to evaluate MCF-7 cell viability after GA treatment. Cell morphological changes were observed follow-up under the inverted microscope after GA withdrawal. To observe the cell apoptosis, DAPI staining was used. Meanwhile, p53 small interfering RNA (si-RNA) was adopted to knock p53 down. All expressions of p53 and bcl-2 were evaluated by Western blot analysis.
RESULTS: MTT assay showed that GA inhibited MCF-7 cell growth effectively in a time-dependent manner. With 0.5 h GA treatment, p53 was significantly increased, whereas bcl-2 was reduced potently with 6 h GA treatment. After GA withdrawal, p53 expressions were maintained in high levels. Furthermore, bcl-2 decreasing was attenuated after co-treatment with PFT alpha, a p53 transcription blocker. Same result was observed after p53 knock-down by p53 si-RNA.
CONCLUSIONS: Gambogic acid induced human breast cancer cells MCF-7 apoptosis by reducing bcl-2 expression via p53.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582475     DOI: 10.1007/s00432-009-0624-2

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  24 in total

1.  Anticancer effect and apoptosis induction of gambogic acid in human gastric cancer line BGC-823.

Authors:  Wei Liu; Qing-Long Guo; Qi-Dong You; Li Zhao; Hong-Yan Gu; Sheng-Tao Yuan
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

2.  Toxicological studies of gambogic acid and its potential targets in experimental animals.

Authors:  Qinglong Guo; Qi Qi; Qidong You; Hongyan Gu; Li Zhao; Zhaoqiu Wu
Journal:  Basic Clin Pharmacol Toxicol       Date:  2006-08       Impact factor: 4.080

3.  WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization.

Authors:  York Tomita; Natasha Marchenko; Susan Erster; Alice Nemajerova; Alexander Dehner; Christian Klein; Hongguang Pan; Horst Kessler; Petr Pancoska; Ute M Moll
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

4.  Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility.

Authors:  Mingxuan Xia; Hartmut Land
Journal:  Nat Struct Mol Biol       Date:  2007-02-18       Impact factor: 15.369

5.  A role for transferrin receptor in triggering apoptosis when targeted with gambogic acid.

Authors:  Shailaja Kasibhatla; Katayoun A Jessen; Sergei Maliartchouk; Jean Yu Wang; Nicole M English; John Drewe; Ling Qiu; Shannon P Archer; Anthony E Ponce; Nilantha Sirisoma; Songchun Jiang; Han-Zhong Zhang; Kurt R Gehlsen; Sui Xiong Cai; Douglas R Green; Ben Tseng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-15       Impact factor: 11.205

6.  Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins.

Authors:  Dayong Zhai; Chaofang Jin; Chung-Wai Shiau; Shinichi Kitada; Arnold C Satterthwait; John C Reed
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

7.  Gambogic acid induces apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric carcinoma MGC-803 cells.

Authors:  Li Zhao; Qing-Long Guo; Qi-Dong You; Zhao-Qiu Wu; Hong-Yan Gu
Journal:  Biol Pharm Bull       Date:  2004-07       Impact factor: 2.233

8.  Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.

Authors:  Na Lu; Yong Yang; Qi-Dong You; Yun Ling; Ying Gao; Hong-Yan Gu; Li Zhao; Xiao-Tang Wang; Qing-Long Guo
Journal:  Cancer Lett       Date:  2007-12-08       Impact factor: 8.679

9.  Gambogic acid induced tumor cell apoptosis by T lymphocyte activation in H22 transplanted mice.

Authors:  Hongyan Gu; Qidong You; Wei Liu; Yong Yang; Li Zhao; Qi Qi; Jie Zhao; Jia Wang; Na Lu; Hua Ling; Qinglong Guo; Xiaotang Wang
Journal:  Int Immunopharmacol       Date:  2008-06-23       Impact factor: 4.932

Review 10.  Control of cell migration: a tumour suppressor function for p53?

Authors:  Lauréline Roger; Gilles Gadea; Pierre Roux
Journal:  Biol Cell       Date:  2006-03       Impact factor: 4.458

View more
  22 in total

Review 1.  Chemistry and biology of the caged Garcinia xanthones.

Authors:  Oraphin Chantarasriwong; Ayse Batova; Warinthorn Chavasiri; Emmanuel A Theodorakis
Journal:  Chemistry       Date:  2010-09-03       Impact factor: 5.236

2.  Gambogic acid inhibits STAT3 phosphorylation through activation of protein tyrosine phosphatase SHP-1: potential role in proliferation and apoptosis.

Authors:  Sahdeo Prasad; Manoj K Pandey; Vivek R Yadav; Bharat B Aggarwal
Journal:  Cancer Prev Res (Phila)       Date:  2011-04-13

3.  Gambogic acid induces apoptosis and inhibits colorectal tumor growth via mitochondrial pathways.

Authors:  Guang-Ming Huang; Yu Sun; Xin Ge; Xin Wan; Chun-Bo Li
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 4.  Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics.

Authors:  Elham Hatami; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-05-31       Impact factor: 10.680

Review 5.  Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals.

Authors:  Subash C Gupta; Ji Hye Kim; Sahdeo Prasad; Bharat B Aggarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

6.  Effects of gambogic acid on the activation of caspase-3 and downregulation of SIRT1 in RPMI-8226 multiple myeloma cells via the accumulation of ROS.

Authors:  Li-Jing Yang; Yan Chen; Jing He; Sha Yi; Lu Wen; Shuai Zhao; Guo-Hui Cui
Journal:  Oncol Lett       Date:  2012-03-06       Impact factor: 2.967

Review 7.  Recent research on bioactive xanthones from natural medicine: Garcinia hanburyi.

Authors:  Buyun Jia; Shanshan Li; Xuerui Hu; Guangyu Zhu; Weidong Chen
Journal:  AAPS PharmSciTech       Date:  2015-07-08       Impact factor: 3.246

Review 8.  Molecular targets of gambogic acid in cancer: recent trends and advancements.

Authors:  Dharambir Kashyap; Rajkumar Mondal; Hardeep Singh Tuli; Gaurav Kumar; Anil K Sharma
Journal:  Tumour Biol       Date:  2016-07-22

9.  Gambogic acid induces mitochondria-dependent apoptosis by modulation of Bcl-2 and Bax in mantle cell lymphoma JeKo-1 cells.

Authors:  Jingyan Xu; Min Zhou; Jian Ouyang; Jing Wang; Qiguo Zhang; Yong Xu; Yueyi Xu; Qian Zhang; Xihui Xu; Hui Zeng
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

10.  Tumor neovasculature-targeted cationic PEGylated liposomes of gambogic acid for the treatment of triple-negative breast cancer.

Authors:  Ravi Doddapaneni; Ketan Patel; Ibtisam Hasan Owaid; Mandip Singh
Journal:  Drug Deliv       Date:  2015-12-24       Impact factor: 6.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.